To examine if β-catenin-TCF4 complexes bind to the CEGRs/ALCDs of GPC3 gene in tumors of HBL patients, we performed a ChIP assay with primers to the CEGR/ALCD in intron 2 of the GPC3 gene. This evidence concerns the gene TCF4 and hepatoblastoma.